Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Scientific Reports|January 30, 2020
Impact of deviation from guideline recommended treatment on breast cancer survival in AsiaPeh Joo Ho, Samuel Guan Wei Ow, Yirong Sim, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 28, 2020
A multicenter phase II randomized trial of durvalumab (MEDI-4736) versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA)Natalie Yl Ngoi, Valerie Heong, Samuel Ow, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 24, 2025
Durvalumab versus physician's choice chemotherapy in recurrent ovarian clear cell adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): a multicenter, randomized, phase 2 trialNatalie Y L Ngoi, Chel Hun Choi, Junxian Zhu, et al.
The Lancet. Oncology|January 18, 2026
Pembrolizumab plus lenvatinib in recurrent gynaecological clear cell carcinoma (LARA): a multicentre, single-arm, phase 2 trialNatalie Y L Ngoi, Jung-Yun Lee, Diana Lim, et al.
Pageof 5